Brief: Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update
March 20 (Reuters) - Skye Bioscience Inc SKYE.O: SKYE BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE SKYE BIOSCIENCE INC: CASH RUNWAY PROJECTED THROUGH AT LEAST Q1 2027 Source text: ID:nGNX5DjBcl Further company coverage: SKYE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug